BioCentury | Nov 14, 2020
Product Development

ASH 2020 snapshot: efficacy data in hot emerging areas

...Therapeutics AG Aruvant Sciences Inc. Forma Therapeutics Inc. Agios Pharmaceuticals Inc. CD47 CD19 CD22 (SIGLEC2) Tumor...
BioCentury | Nov 12, 2020
Product Development

Lining up allogeneic CAR Ts at ASH: Data Byte

...Therapeutics Inc. Cellectis S.A. Nanjing Bioheng Biotech Co. Ltd. Celyad S.A. CD19 CD22 (SIGLEC2) Tumor...
BioCentury | Jan 4, 2020
Targets & Mechanisms

SIGLECs go from homing beacons to next-generation checkpoints

...sugar-binding proteins could prove useful outside of cancer as well. Two members of the family, CD22 (SIGLEC2)...
...proteins ( bottom ). For each target, the most advanced development stage is listed. Targets: CD22 (SIGLEC2)...
...mask, but if you have nothing to hide, there's nothing to be worried about." Targets CD22 (SIGLEC2)...
Items per page:
1 - 3 of 3